Culture

Future of Cannabis Research in the US

Cannabis research in the United States is entering a period of transition. For decades, scientific study has been limited by federal restrictions, even as consumer demand and state-level legalization continued to grow. With recent movement toward federal reclassification and increased interest in cannabinoids like CBD and THCa, the research landscape is beginning to shift.

A Brief History of Cannabis Scheduling

Cannabis has long been classified as a Schedule I substance under the Controlled Substances Act. This category is reserved for substances considered to have a high potential for abuse and no accepted medical use, placing cannabis alongside drugs like heroin.

In 2024, the U.S. Department of Health and Human Services recommended moving cannabis to Schedule III, which includes substances with recognized medical use and lower abuse potential. The Drug Enforcement Administration is currently reviewing this recommendation, marking a potential turning point in federal policy.

Barriers That Have Slowed Research

Despite growing interest, several challenges have limited progress in cannabis research.

Restricted Access to Research Material

Researchers have historically been required to source cannabis from federally approved facilities. This limited supply has not reflected the variety or potency of products available in legal markets.

Complex Approval Processes

Cannabis research often requires multiple layers of approval, including:

These processes can take years, discouraging many institutions from pursuing studies.

Funding Limitations

Federal funding has traditionally focused on potential risks rather than benefits. While that is beginning to shift, gaps in funding still limit large-scale research efforts.

The National Institutes of Health continues to track ongoing studies and funding opportunities.

What Reclassification Could Change

If cannabis moves to Schedule III, it could significantly reshape the research environment.

Easier Research Access

Reduced restrictions may allow universities and private institutions to obtain cannabis more easily, improving both the quantity and quality of studies.

Expanded Clinical Trials

More clinical trials could explore cannabinoids such as:

CBD
THC
THCa

This could lead to better understanding of dosing, safety, and long-term effects.

Increased Private Sector Involvement

Pharmaceutical and biotech companies may be more willing to invest in cannabis research, accelerating product development and standardization.

Emerging Research Opportunities

As policy evolves, new areas of research are gaining attention.

Cannabinoid-Specific Studies

Beyond THC and CBD, compounds like CBG, CBN, and THCa are becoming a focus as researchers explore how they interact with the body.

The Endocannabinoid System

Research continues to examine how cannabinoids influence the endocannabinoid system, which plays a role in mood, appetite, and sleep.

Product Safety and Standardization

With more hemp-derived products on the market, there is increasing demand for consistent testing, labeling, and quality control.

Long-Term Health Effects

There is still limited data on long-term cannabis use, especially for newer product formats like infused beverages and high-THCa flower.

Implications for North Carolina

North Carolina remains in a unique position. While adult-use marijuana is not legal, the state has a growing hemp market supported by federal law.

Hemp and THCa Market Growth

THCa products have gained traction due to their compliance with federal hemp definitions, as long as delta-9 THC remains below 0.3 percent by dry weight.

Research Opportunities in the State

If restrictions ease, institutions like University of North Carolina system and North Carolina State University could expand research efforts in areas such as:

Hemp cultivation
Cannabinoid science
Product testing and development

Regulatory Considerations

The North Carolina Department of Agriculture and Consumer Services continues to provide guidance on hemp regulations, which may evolve alongside federal changes.

Ongoing Challenges

Even with reclassification, several issues remain.

Conflicts between state and federal laws
Lack of standardization across products
Public health considerations as access expands

These factors continue to shape how research and policy develop.

Where Research Is Headed

The future of cannabis research in the United States will likely be shaped by policy reform, scientific advancement, and market demand. Reclassification could open new doors, but it is only one piece of a larger shift.

For North Carolina, this evolving landscape may create new opportunities in research, education, and economic development, particularly within the hemp and THCa space.

At the same time, continued research will be essential to better understand both the benefits and limitations of cannabis, helping consumers and policymakers make more informed decisions.